Quote | Stevanato Group S.p.A. (NYSE:STVN)
Last: | $17.98 |
---|---|
Change Percent: | 0.0% |
Open: | $18.11 |
Close: | $17.98 |
High: | $18.165 |
Low: | $17.48 |
Volume: | 316,842 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Stevanato Group S.p.A. (NYSE:STVN)
2024-06-24 21:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Cisterna’s site is the first to implement premium solutions outside the Group’s headquarters in Piombino Dese to meet the growing demand for biopharmaceuticals, such as GLP-1s in Europe. Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containme...
Message Board Posts | Stevanato Group S.p.A. (NYSE:STVN)
Subject | By | Source | When |
---|---|---|---|
$STVN $50 TARGET PRICE WOOHOOOOOO | weedtrader420 | investorshub | 09/04/2021 9:46:20 AM |
Picks and shovels! Love it! | Glider549 | investorshub | 08/12/2021 1:47:21 AM |
Owns 80% of the vaccine Bottling business | weedtrader420 | investorshub | 07/16/2021 5:30:17 PM |
News, Short Squeeze, Breakout and More Instantly...
Stevanato Group S.p.A. Company Name:
STVN Stock Symbol:
NYSE Market:
Stevanato Group S.p.A. Website:
2024-06-24 21:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Cisterna’s site is the first to implement premium solutions outside the Group’s headquarters in Piombino Dese to meet the growing demand for biopharmaceuticals, such as GLP-1s in Europe. Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containme...
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced today that its Board of Directors has appointed Franco Stevanato, a current director and the Exec...